Terms: = Endocrine gland cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
23 results:
1. The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
Nie X; Xu T; Zhang L; Cheng W
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():97-104. PubMed ID: 38219610
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
Li Y; Gao X; Guo T; Liu J
Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
[TBL] [Abstract] [Full Text] [Related]
3. Coexisting Papillary and Anaplastic Thyroid cancer: Elucidating the Spectrum of Aggressive Behavior.
Greenberg JA; Moore MD; Thiesmeyer JW; Egan CE; Lee YJ; Christos P; Zarnegar R; Beninato T; Fahey Iii TJ; Finnerty BM
Ann Surg Oncol; 2023 Jan; 30(1):137-145. PubMed ID: 36224511
[TBL] [Abstract] [Full Text] [Related]
4. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Frenel JS; Kim JW; Aryal N; Asher R; Berton D; Vidal L; Pautier P; Ledermann JA; Penson RT; Oza AM; Korach J; Huzarski T; Pignata S; Colombo N; Park-Simon TW; Tamura K; Sonke GS; Freimund AE; Lee CK; Pujade-Lauraine E
Ann Oncol; 2022 Oct; 33(10):1021-1028. PubMed ID: 35772665
[TBL] [Abstract] [Full Text] [Related]
6. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract] [Full Text] [Related]
7. A Nomogram for Predicting Intraoperative Hemodynamic Instability in Patients With Pheochromocytoma.
Zhang Z; Ye Y; Yu J; Liao S; Pan W; Guo Y; Jiang S; Luo C; Zheng F
Front Endocrinol (Lausanne); 2021; 12():787786. PubMed ID: 35069440
[TBL] [Abstract] [Full Text] [Related]
8. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid cancer Patients: A Retrospective Study in Southwest China.
Liu Q; Yin M; Li G
Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
[TBL] [Abstract] [Full Text] [Related]
9. Dynamic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Zhuo X; Yu J; Chen Z; Lin Z; Huang X; Chen Q; Zhu H; Wan Y
Otolaryngol Head Neck Surg; 2022 Mar; 166(3):444-453. PubMed ID: 34058905
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.
Tasaka N; Minaguchi T; Hosokawa Y; Takao W; Itagaki H; Nishida K; Akiyama A; Shikama A; Ochi H; Satoh T
J Obstet Gynaecol Res; 2020 May; 46(5):765-773. PubMed ID: 32147891
[TBL] [Abstract] [Full Text] [Related]
11. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.
Cho J; Scragg R; Pandol SJ; Goodarzi MO; Petrov MS
Diabetes Care; 2019 Sep; 42(9):1675-1683. PubMed ID: 31227582
[TBL] [Abstract] [Full Text] [Related]
12. Model for Prediction of Optimal Debulking of Epithelial Ovarian cancer.
Arab M; Jamdar F; Sadat Hosseini M; Ghodssi- Ghasemabadi R; Farzaneh F; Ashrafganjoei T
Asian Pac J Cancer Prev; 2018 May; 19(5):1319-1324. PubMed ID: 29802693
[TBL] [Abstract] [Full Text] [Related]
13. Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-runx1t1 Rearrangement.
Tokunaga K; Yamamura A; Ueno S; Kikukawa Y; Yamaguchi S; Hidaka M; Matsuno N; Kawaguchi T; Matsuoka M; Okuno Y
Intern Med; 2018 Feb; 57(4):563-568. PubMed ID: 29151502
[TBL] [Abstract] [Full Text] [Related]
14. Early versus delayed initiation of adjuvant treatment for pancreatic cancer.
Kim HW; Lee JC; Lee J; Kim JW; Kim J; Hwang JH
PLoS One; 2017; 12(3):e0173960. PubMed ID: 28301556
[TBL] [Abstract] [Full Text] [Related]
15. Cost Effectiveness Analysis of Different Management Strategies between Best Supportive Care and Second-line Chemotherapy for Platinum-resistant or Refractory Ovarian cancer.
Luealon P; Khempech N; Vasuratna A; Hanvoravongchai P; Havanond P
Asian Pac J Cancer Prev; 2016; 17(2):799-805. PubMed ID: 26925683
[TBL] [Abstract] [Full Text] [Related]
16. [Necessity of central lymph node dissection in management of papillary thyroid microcarcinoma].
Xu X; Jiang B; Han L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):362-5. PubMed ID: 24961119
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer.
Shim SH; Kim DY; Seo MJ; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2013 Oct; 23(8):1383-92. PubMed ID: 24257552
[TBL] [Abstract] [Full Text] [Related]
18. Bowel obstruction in elderly ovarian cancer patients: a population-based study.
Mooney SJ; Winner M; Hershman DL; Wright JD; Feingold DL; Allendorf JD; Neugut AI
Gynecol Oncol; 2013 Apr; 129(1):107-12. PubMed ID: 23274561
[TBL] [Abstract] [Full Text] [Related]
19. Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, runx1t1 in ovarian cancer.
Yeh KT; Chen TH; Yang HW; Chou JL; Chen LY; Yeh CM; Chen YH; Lin RI; Su HY; Chen GC; Deatherage DE; Huang YW; Yan PS; Lin HJ; Nephew KP; Huang TH; Lai HC; Chan MW
Epigenetics; 2011 Jun; 6(6):727-39. PubMed ID: 21540640
[TBL] [Abstract] [Full Text] [Related]
20. Response of ACTH to octreotide in a probable corticotropic adenoma associated with Addison's disease.
Suárez-Llanos JP; Fernández-Fernández E; Checa MR; Jara-Albarrán A
Neuro Endocrinol Lett; 2007 Oct; 28(5):549-53. PubMed ID: 17984930
[TBL] [Abstract] [Full Text] [Related]
[Next]
